The announcement of the inaugural Future Leader Fellows for Clinical Trials program offers more than a story about research funding — it is a reminder of the depth of talent that African Australian professionals bring to this country’s health system. Among the six clinicians selected through a competitive process is Dr Violet Mukaro, Senior Project Officer at the University of Melbourne, whose appointment places African Australian leadership at the centre of a $2 million Victorian Government effort to transform how clinical trials reach the communities they serve. Her inclusion in this cohort is not symbolic. It reflects a pattern that those working in Australian healthcare know well: health and medical research remain among the most significant sectors of skilled African Australian employment, and the contribution of these professionals extends far beyond their own career trajectories into the science and wellbeing of the broader community.
The program, backed by $2 million through the Victorian Government’s Economic Growth Statement, will appoint 15 Fellows over the next three years. It is delivered by the Victorian Research Translation Centre Collaborative (VRTCC), a partnership comprising the Melbourne Academic Centre for Health (MACH), Monash Partners Health Translation Network and Western Alliance Academic Health Science Centre. The Fellowships provide protected time and support for frontline health professionals to develop and test practical approaches to increasing participation in clinical trials. The inaugural cohort — Dr Lucy Attwood, Dr Michelle Gooey, Dr Anna Watts, Dr Anna Cunliffe, Professor Justin Yeung and Dr Violet Mukaro — was chosen following a competitive selection process and will work directly with clinical trial sponsors, health services, researchers and communities.
Dr Violet Mukaro (left) and Professor Justin Yeung (right) – (Photo source : MACH Australia )
Dr Mukaro’s project, administered through the Melbourne Centre for Clinical Trials (MCCT), will see her work with Austin Health and Melbourne Health to improve participation in clinical trials among African Australian communities. Working directly with community members, she will develop and test culturally appropriate recruitment and consent approaches for critical care clinical trials. The project will produce community-informed resources and engagement approaches designed to improve awareness, trust and participation in clinical research. While initially focused on African Australian communities, the work could inform broader efforts among culturally and linguistically diverse communities across Victoria — a reminder that when African Australian professionals lead, the benefits routinely extend well past their own communities.
That Dr Mukaro’s project emerges from within the health sector is unsurprising. Health, nursing, allied health and medical research have long been among the leading destinations for skilled African migrants and African Australian graduates — a concentration that stands out when compared with many other industries. This is not incidental. It reflects both the accessibility of health careers to internationally trained professionals and a genuine vocational orientation toward care, science and community service. The consequence is that African Australian professionals are embedded at every level of the system: in hospitals, in laboratories, in community health organisations, in universities, and increasingly in leadership and research roles that shape how medicine is practised and studied in this country.
Contact iMove Solutions for your domestic and residential relocations
The significance of Dr Mukaro’s work lies precisely in this intersection of representation and scientific rigour. Clinical trials are the mechanism through which medical breakthroughs become real-world treatments, and their value depends on the participation of diverse populations. When particular communities are under-represented — whether through mistrust, language barriers, culturally inappropriate consent processes or simple lack of awareness — the evidence base itself is weakened, and the benefits of research are distributed unevenly. Dr Mukaro’s project addresses this directly by building trust and participation in African Australian communities, with implications for how the entire research enterprise understands and engages with diversity.
The Fellowship program’s broader design reinforces this emphasis on access. Professor Justin Yeung, Consultant Colorectal Surgeon at Western Health and Acting Head of the Department of Surgery at the University of Melbourne, will develop and test two digital tools to improve participation in oncology clinical trials — a dashboard using hospital data to identify potentially eligible participants, alongside a patient-facing app to help people understand and access trial opportunities. The inaugural cohort’s collective focus spans multicultural communities, First Nations people and regional Victorians. As MCCT Director Professor Julie Simpson observed, the projects tackle different challenges but share the potential to broaden involvement in clinical trials and strengthen access to research opportunities.
For the AMA and its members, there are two reasons to take note. The first is the practical value of this work: better recruitment and retention in clinical trials means earlier introduction of new treatments, stronger evidence, and more commercial investment flowing into Australian research — a point made by VRTCC Independent Chair Professor Richard Larkins AC. The second is the broader lesson about who is doing that work. The appointment of Dr Mukaro to this inaugural cohort is a well-deserved individual recognition, but it also illuminates the wider contribution of African Australian health professionals to Australian medicine. Supporting that contribution — through Fellowship programs like this, through equitable pathways into research and leadership, and through genuine engagement with the communities these clinicians serve — is not simply a matter of equity. It is a direct investment in the quality, reach and credibility of Australian health science.
J.D Sharady | AMA contributor
